Javascript must be enabled to continue!
Abstract 1543: Regulatory role of miR-410 in prostate cancer
View through CrossRef
Abstract
Prostate cancer (PCa), a leading cause of male cancer related mortality, is dependent upon androgens acting via androgen receptor (AR) signaling. Androgen targeted therapies are often used as the first line of treatment for prostate cancer that are effective initially. However, PCa eventually progresses to castration-resistant stage that has limited treatment options. Castration-resistant prostate cancer (CRPC) is treated by second generation of AR pathway inhibitors such as Enzalutamide and Abiraterone. Resistance to these agents develop owing to various mechanisms such as evolution to androgen-independent neuroendocrine prostate cancer (NEPC). In this study, we examined the potential role of miR-410 in different stages of prostate cancer. Analyses of miR-410 in PCa clinical samples and patient-derived xenograft (PDX) models showed that miR-410 is frequently upregulated in PCa. Its expression was further increased in CRPC cases with neuroendocrine differentiation (NED). We examined the functional role of miR-410 by stably expressing miR-410 in androgen dependent and androgen independent cell lines. Our data suggests a context dependent role of miR-410 in prostate cancer cell lines. In androgen independent cell line, miR-410 plays an oncogenic role by impacting epithelial to mesenchymal transition (EMT) via directly targeting SNAIL. Also, it was found to increase the expression of neuronal genes such as Synaptophysin and neural transcription factor BRN2. However, in androgen dependent cell line, miR-410 was found to target PTEN. In conclusion, our data suggests that miR-410 play an important regulatory role in prostate cancer with effects on EMT and neuronal differentiation programs.
Citation Format: Amritha Sreekumar, Nikhil Patel, Sharanjot Saini. Regulatory role of miR-410 in prostate cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1543.
American Association for Cancer Research (AACR)
Title: Abstract 1543: Regulatory role of miR-410 in prostate cancer
Description:
Abstract
Prostate cancer (PCa), a leading cause of male cancer related mortality, is dependent upon androgens acting via androgen receptor (AR) signaling.
Androgen targeted therapies are often used as the first line of treatment for prostate cancer that are effective initially.
However, PCa eventually progresses to castration-resistant stage that has limited treatment options.
Castration-resistant prostate cancer (CRPC) is treated by second generation of AR pathway inhibitors such as Enzalutamide and Abiraterone.
Resistance to these agents develop owing to various mechanisms such as evolution to androgen-independent neuroendocrine prostate cancer (NEPC).
In this study, we examined the potential role of miR-410 in different stages of prostate cancer.
Analyses of miR-410 in PCa clinical samples and patient-derived xenograft (PDX) models showed that miR-410 is frequently upregulated in PCa.
Its expression was further increased in CRPC cases with neuroendocrine differentiation (NED).
We examined the functional role of miR-410 by stably expressing miR-410 in androgen dependent and androgen independent cell lines.
Our data suggests a context dependent role of miR-410 in prostate cancer cell lines.
In androgen independent cell line, miR-410 plays an oncogenic role by impacting epithelial to mesenchymal transition (EMT) via directly targeting SNAIL.
Also, it was found to increase the expression of neuronal genes such as Synaptophysin and neural transcription factor BRN2.
However, in androgen dependent cell line, miR-410 was found to target PTEN.
In conclusion, our data suggests that miR-410 play an important regulatory role in prostate cancer with effects on EMT and neuronal differentiation programs.
Citation Format: Amritha Sreekumar, Nikhil Patel, Sharanjot Saini.
Regulatory role of miR-410 in prostate cancer [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13.
Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1543.
Related Results
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
Introduction: Acute myocardial infarction (AMI) is a severe coronary heart disease. Targeted miRNAs studies implicated two main pathways in the regulation of AMI namely pro-apopt...
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
Abstract
Background
MicroRNAs (miRNAs) can function as either oncogenes or tumor suppressor genes via regulation of cell proliferation and/or apo...
Oncomirnas and Tumor Suppressors In Microvesicles From Four Types Of Cancer
Oncomirnas and Tumor Suppressors In Microvesicles From Four Types Of Cancer
Abstract
Objectives
Microvesicles (MVs) are small vesicles that are shed from almost all cell types including cancer cells into ...
Abstract 1794: A comparative microRNA expression analysis in breast cancer and melanoma tissues
Abstract 1794: A comparative microRNA expression analysis in breast cancer and melanoma tissues
Abstract
Recently studies have revealed that a subset of microRNAs (miRNAs) is aberrantly expressed in the development and progression of a variety of cancers inc...
miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
Abstract
Traditional research modes aim to find cancer-specific single therapeutic target. Recently, emerging evidence suggested that some micro-RNAs (miRNA) can fun...
The effect of miR-138 on the proliferation and apoptosis of breast cancer cells
through the NF-κB/VEGF signaling pathway
The effect of miR-138 on the proliferation and apoptosis of breast cancer cells
through the NF-κB/VEGF signaling pathway
The analyze the effect of miR-138 on the proliferation and apoptosis of breast cancer cells through the
NF-κB/VEGF signaling pathway is the Objective of this experiment. For this a...
Data from miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
Data from miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
<div>Abstract<p>Traditional research modes aim to find cancer-specific single therapeutic target. Recently, emerging evidence suggested that some micro-RNAs (miRNA) can...
Data from miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
Data from miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
<div>Abstract<p>Traditional research modes aim to find cancer-specific single therapeutic target. Recently, emerging evidence suggested that some micro-RNAs (miRNA) can...

